openPR Logo
Press release

Mycoplasma Diagnostics Market Analysis, Applications Share, Trends & Forecast to 2024

05-04-2017 08:04 PM CET | Health & Medicine

Press release from: Transparency Market Research

Mycoplasma Diagnostics Market Analysis, Applications Share,

Global Mycoplasma Diagnostics Market: Snapshot

Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests. But decline in cost per sample analysis and labor cost, improvements in automation and introduction of advanced technologies has extended the usage of molecular diagnostics in wide range of applications. The market for mycoplasma diagnostics has expanded since 1990’s with the introduction of PCR. It is estimated that in the U.S. over 600 laboratories and 200 independent laboratories perform mycoplasma diagnostics test to simplify and accelerate the testing process.

The global mycoplasma diagnostics market, which stood at US$602.0 mn in 2016, is forecast to reach US$1.35 bn by the end of 2024. If these figures hold true, the market will exhibit a CAGR of 10.6% between 2016 and 2024.

Demand for Software & Services Projected to Increase at High Pace
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.

View Report @ http://www.transparencymarketresearch.com/mycoplasma-diagnostics-market.html

By technology, PCR, immunoassay, DNA staining, microbial culture techniques and others are the key market segments. Currently, the PCR segment contributes the largest share in the revenue generated by the market based on technology. The demand for PCR is forecast to increase considerably in the coming years owing to the rising incidence of hospital acquired infections. The diagnostic technology provides rapid turnaround time, reduction in cost of sequencing, and sensitivity. As end users get to know benefits offered by PCR, the demand from the segment will increase in response.

By end users, global mycoplasma diagnostic market is dominated by hospitals & diagnostic laboratories. Hospitals & diagnostic laboratories are an importantchannel for the usage of multiplexed diagnostic products & offer a range of diagnosis solutions. They are an important channel for the usage of multiplexed diagnostic products. According to the norms of government health care facilities, they offer reimbursement plans and advanced technology systems for treatment.

North America Holds Dominance, But Asia Pacific to Report Higher CAGR

Regionally, North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa constitute the key market segments. Among these regions, North America held dominance in 2016 with an estimated share of 35.4% in the overall market. Several large research laboratories are present in North America. Besides this, the region also boasts a high level of public awareness, which provides an environment conducive to the growth of the mycoplasma diagnostics market. Furthermore, in the coming years, the market is expected to gain from the increasing demand for point of care testing.

Despite dominance exercised by the North America market, during the forecast period Asia Pacific will showcase more lucrative opportunities. Besides the high incidence of respiratory tract infection witnessed in the last few years, the emerging nations in the region boasts high healthcare spending, which has helped the mycoplasma market exhibit strong growth in Asia Pacific. In addition, the regional market is forecast to gain from the rising demand for personalized medicines, rise in research and development investments, and the rising public awareness.

Key players operating in this market include F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius Stedim BioOutsource Limited, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck KGaA, and Charles River Laboratories International, Inc. among others.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving mycoplasma diagnostics market during 2016 - 2024

Get accurate market forecast and analysis on the mycoplasma diagnostics market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1677

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mycoplasma Diagnostics Market Analysis, Applications Share, Trends & Forecast to 2024 here

News-ID: 524726 • Views: 374

More Releases from Transparency Market Research

Voltage Detectors Market – Evolving Technology Trends and Industry SWOT Analys …
The global voltage detectors market includes large number of players. Some of the key players are Texas Instruments, Toshiba, ROHM Semiconductor Sharp Microelectronics, Analog Devices Inc., STMicroelectronics, ON Semiconductor, Torex Semiconductor, Taiwan Semiconductor and Seiko Instruments. Browse Our Report @ https://www.transparencymarketresearch.com/voltage-detectors-market.html Voltage Detector is a testing equipment generally used to determine the existence or absence of an electrical charge in an object. It is highly suggested for conditions where power issues exist.
Switched Capacitor Filters Market : Key Segments, Maket Insights, Regional Outlo …
Major players in the global switched capacitor filters market are Texas Instruments Incorporated, Analog Devices, Inc., Maxim Integrated, Inc., Siemens AG, Eaton Corporation, and among others. Browse Our Report @ https://www.transparencymarketresearch.com/switched-capacitor-filters-market.html A switched capacitor filter is an active filter based on the consideration that a switching of capacitors between two circuit nodes at an adequately high rate that is equivalent to a resistor connecting these two nodes. The switched capacitor filters are
Current Calibrator Market : Recent Industry Developments And Growth Strategies A …
Key players operating in the global current calibrator market include Valhalla Scientific, Rotek Inc., Time Electronics, PCE Instruments, Martel Electronics, AOIP Instrumentation, Extech Instruments, Yogokawa Test & Measurement Corporation, Extech Instruments, REED Instruments, Fluke Corporation, and others. These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the
Damp Meter Market – Outlook by Responsible Drivers, Restraints, Demand
Key players operating in the global damp meter market include PCE Instrument, Delmhorst Instrument Co., GENERAL TOOLS & INSTRUMENTS LLC, FLIR Systems, Inc. designs, Panomex Inc., These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the global market are collaborations, partnerships, agreements, and new product launches. The

All 5 Releases


More Releases for Mycoplasma

Mycoplasma Detection Systems Market Revenue and Growth Rate 2018-2027
Common contaminants in the biopharmaceutical industry, mycoplasmas go undetected without causing any visible changes in cell cultures. Detection of mycoplasma DNA through conventional methods is time-consuming and labor intensive. To resolve the difficulty of detecting mycoplasma macroscopically, cell culturists and microbiologists have been continuously putting efforts to develop most sensitive methods with regard to assay for mycoplasma detection in cell cultures. The requirement for efficient and accurate mycoplasma detection systems has
Mycoplasma Diagnostics Market Opportunity Analysis by 2024
The global market for mycoplasma disorder featured the top five vendors, namely Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Merck KGaA, Agilent Technologies, and Lonza Group accounting for over 68% of the overall market in 2016, observes Transparency Market Research (TMR) in a recent report. The high level of consolidation has ensued intense competition and increased focus of leading vendors on mergers and acquisitions, geographical expansion, and introduction of technologically
Mycoplasma Diagnostics Market to Reach US$ 1.35 Billion in 2024
Transparency Market Research states that the global mycoplasma diagnostics market will expand at a promising 10.6% CAGR over the period between 2016 and 2024, rising from a valuation of US$602.0 mn in 2016 to US$1.35 bn in 2024. The vast rise in the rate of prevalence of respiratory tract infections has emerged as the key growth driver for the global mycoplasma diagnostics market in the past few years. A report
Mycoplasma Diagnostics Market Demand is Increasing
Global Mycoplasma Diagnostics Market: Snapshot Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry.  Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost
Global Mycoplasma Diagnostics Market Analysis
Albany, New York, May 3, 2017: This report on Mycoplasma Diagnostics Studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various mycoplasma techniques and products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of
Global Mycoplasma Testing Market Research Report 2017
Qyresearchreports include new market research report "Global Mycoplasma Testing Market Research Report 2017" to its huge collection of research reports. Various factors are responsible for the high revenue growth witnessed in the global Mycoplasma Testing market. However there are a few restraints as well forecast to challenge the market’s trajectory. Nevertheless, through the course of the forecast period starting from 2016 to 2021, the market will continue exhibiting steady growth. The